机读格式显示(MARC)

• 000 01420nam a2200193 a 4500

• 001 0000841172

• 005 20250911204900.0

• 008 221024s2021 flu 000 0 eng d

• 020 __ |a 9781032242453 (pbk.) :

• 040 __ |a CEPC1 |c CEPC1

• 090 __ |a R318/X2

• 093 __ |a R318 |2 5

• 100 1_ |a Rabbee, Nusrat.

• 245 10 |a Biomarker analysis in clinical trials with R / |c Nusrat Rabbee.

• 260 __ |a Boca Raton, FL : |b CRC Press, |c 2021.

• 300 __ |a 228 p. ; |c 24 cm.

• 520 __ |a The world is awash in data. This volume of data will continue to increase. In the pharmaceutical industry, much of this data explosion has happened around biomarker data. Great statisticians are needed to derive understanding from these data. This book will guide you as you begin the journey into communicating, understanding and synthesizing biomarker data. -From the Foreword, Jared Christensen, Vice President, Biostatistics Early Clinical Development, Pfizer, Inc. Biomarker Analysis in Clinical Trials with R offers practical guidance to statisticians in the pharmaceutical industry on how to incorporate biomarker data analysis in clinical trial studies. The book discusses the appropriate statistical methods for evaluating pharmacodynamic, predictive and surrogate biomarkers for delivering increased value in the drug development process.

• 650 _0 |a Biochemical markers |x Statistical methods.

• 650 _0 |a Clinical trials |x Statistical methods.